Willingness to pay for booster dose of COVID-19 vaccine among healthcare workers in Taizhou,China

References

• Majumder J, Minko T. Recent developments on therapeutic and diagnostic approaches for COVID-19. Aaps J. 2021;23(1):14. doi:10.1208/s12248-020-00532-2.
   PubMed Web of Science ®Google Scholar
• Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603–5. doi:10.1056/NEJMoa2034577.
   PubMed Web of Science ®Google Scholar
• Russell FM, Greenwood B. Who should be prioritised for COVID-19 vaccination? Hum Vaccin Immunother. 2021;17(5):1317–21. doi:10.1080/21645515.2020.1827882.
   PubMed Web of Science ®Google Scholar
• Committee on Infectious Diseases. Universal hepatitis B immunization. Pedi-Atrics. 1992;4:795–800. doi:10.1542/peds.89.4.795.
   Google Scholar
• Gay NJ. The theory of measles elimination:implications for the design of elimination strategies. J Infect Dis. 2004;189(suppl 1):S27–35. doi:10.1086/381592.
   PubMed Web of Science ®Google Scholar
• Naaber P, Tserel L, Kangro K, Sepp E, Jürjenson V, Adamson A, Haljasmägi L, Rumm AP, Maruste R, Kärner J, et al. Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study. Lancet Reg Health Eur. 2021 ;10:100208. Epub 2021 Sep 6. PMID: 34514454; PMCID:PMC8418937. doi:10.1016/j.lanepe.2021.100208.
   PubMedGoogle Scholar
• Sabetian G, Moghadami M, Hashemizadeh Fard Haghighi L, Shahriarirad R, Fallahi MJ, Asmarian N, Moeini YS. COVID-19 infection among healthcare workers: a cross-sectional study in southwest Iran. Virol J. 2021;18(1):58. PMID: 33731169. doi:10.1186/s12985-021-01532-0.
   PubMed Web of Science ®Google Scholar
• Euronews: at least 90,000 healthcare workers infected by COVID-19’, says nursing group. [accessed 8 July]. https://www.euronews.com/2020/05/06/at-least90-000-healthcare-workers-infected-by-covid-19-says-nursing-group
   Google Scholar
• Zheng L, Wang X, Zhou C, Liu Q, Li S, Sun Q, Wang M, Zhou Q, Wang W. Analysis of the infection status of the health care workers in Wuhan during the COVID-19 outbreak: a cross-sectional study. Clin Infect Dis. 2020;71:2109–13. doi:10.1093/cid/ciaa588.
   PubMed Web of Science ®Google Scholar
• Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, Setiawan AM, Rajamoorthy Y, Sofyan H, Vo TQ, et al. Willingness-To-Pay for a COVID-19 vaccine and its associated determinants in Indonesia. Hum Vaccin Immunother. 2020 ;16(12):3074–80. Epub 2020 Sep 29.PMID: 32991230. doi:10.1080/21645515.2020.1819741.
   PubMed Web of Science ®Google Scholar
• Wong LP, Alias H, Wong PF, Lee HY, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vaccin Immunother. 2020;16(9):2204–14. Epub 2020 Jul 30. PMID 32730103. doi:10.1080/21645515.2020.1790279.
   PubMed Web of Science ®Google Scholar
• Wang J, Lyu Y, Zhang H, Jing R, Lai X, Feng H, Knoll MD, Fang H. Willingness to pay and financing preferences for COVID-19 vaccination in China. Vaccine. 2021 ;39(14):1968–76. Epub 2021 Feb 27.PMID: 33714653. doi:10.1016/j.vaccine.2021.02.060.
   PubMed Web of Science ®Google Scholar
• Cerda AA, García LY. Willingness to pay for a COVID-19 vaccine. Appl Health Econ Health Policy. 2021;19(3):343–51. Epub 2021 Feb 23. PMID: 33619688. doi:10.1007/s40258-021-00644-6.
   PubMed Web of Science ®Google Scholar
• Kabir R, Mahmud I, Chowdhury MTH, Vinnakota D, Jahan SS, Siddika N, Isha SN, Nath SK, Hoque Apu E. COVID-19 vaccination intent and willingness to pay in Bangladesh: a cross-sectional study. Vaccines (Basel). 2021;9(5):416. PMID:33919254. doi:10.3390/vaccines9050416.
   PubMed Web of Science ®Google Scholar
• Han K, Francis MR, Zhang R, Wang Q, Xia A, Lu L, Yang B, Hou Z. Confidence, acceptance and willingness to pay for the COVID-19 vaccine among migrants in Shanghai, China: a cross-sectional study. Vaccines (Basel). 2021;9(5):443. PMID:34063182. doi:10.3390/vaccines9050443.
   PubMed Web of Science ®Google Scholar
• Adigwe OP. COVID-19 vaccine hesitancy and willingness to pay: Emergent factors from a cross-sectional study in Nigeria. Vaccine X. 2021;9:100112. doi:10.1016/j.jvacx.2021.100112. Epub 2021 Sep 3.PMID: 34494000.
   PubMedGoogle Scholar
• Qin W, Wang E, Ni Z. Chinese consumers’ willingness to get a COVID-19 vaccine and willingness to pay for it. PLoS One. 2021 May 4;16(5):e0250112. eCollection 2021.PMID: 33945544. doi:10.1371/journal.pone.0250112.
   PubMed Web of Science ®Google Scholar
• Hao F, Wang B, Tan W, Husain SF, McIntyre RS, Tang X, Zhang L, Han X, Jiang L, Chew NWS, et al. Attitudes toward COVID-19 vaccination and willingness to pay: comparison of people with and without mental disorders in China. Bjpsych Open. 2021 Aug 11;7(5):e146. eCollection 2021 Sep. DOI:10.1192/bjo.2021.979. PMID: 34422295. doi:10.1192/bjo.2021.979.
   PubMed Web of Science ®Google Scholar
• Shitu K, Wolde M, Handebo S, Kassie A. Acceptance and willingness to pay for COVID-19 vaccine among school teachers in Gondar City, Northwest Ethiopia. Trop Med Health. 2021 ;49(1):63. PMID: 34372943. doi:10.1186/s41182-021-00337-9.
   PubMed Web of Science ®Google Scholar
• Banik R, Islam MS, Pranta MUR, Rahman QM, Rahman M, Pardhan S, Driscoll R, Hossain S, Sikder MT. Understanding the determinants of COVID-19 vaccination intention and willingness to pay: findings from a population-based survey in Bangladesh. BMC Infect Dis. 2021;21(1):892. PMID: 34465297. doi:10.1186/s12879-021-06406-y.
   PubMed Web of Science ®Google Scholar
• Arshad MS, Hussain I, Mahmood T, Hayat K, Majeed A, Imran I, Saeed H, Iqbal MO, Uzair M, Rehman AU, et al. A national survey to assess the COVID-19 vaccine-related conspiracy beliefs, acceptability, preference, and willingness to pay among the general population of Pakistan. Vaccines (Basel). 2021;9(7):720. PMID:34358136. doi:10.3390/vaccines9070720.
   PubMed Web of Science ®Google Scholar
• Campbell ZA, Otieno L, Shirima GM, Marsh TL, Palmer GH. Using contingent valuation method to estimate adults’ willingness to pay for a future coronavirus 2019 vaccination. Value Health Reg Issues. 2021;24:240–46. PMID:30478006. doi:10.1016/j.vaccine.2018.11.058.
   PubMedGoogle Scholar
• Munro APS, Janani L, Cornelius V, Aley PK, Babbage G, Baxter D, Bula M, Cathie K, Chatterjee K, Dodd K, et al. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdox1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. Lancet. 2021;398(10318):2258–76. Epub 2021 Dec 2. PMID: 34863358 Free PMC article. Clinical Trial. doi:10.1016/S0140-6736(21)02717-3.
   PubMed Web of Science ®Google Scholar